Safety of etanercept in elderly subjects with rheumatoid arthritis
Alfredomaria Lurati, Mariagrazia Marrazza, Katia Angela, Magda ScarpelliniFornaroli Hospital, Rheumatology Unit, Magenta, ItalyObjective: To report side effects seen in a clinical cohort of patients aged >65 years with rheumatoid arthritis (RA) treated with the tumor necrosis factor-&...
Guardado en:
Autores principales: | Alfredomaria Lurati, Mariagrazia Marrazza, Katia Angela, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/05b1d4b27c8f4ca786a3aba79ddb5a55 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis
por: Kivelevitch D, et al.
Publicado: (2014) -
NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab
por: Re KA, et al.
Publicado: (2012) -
NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
por: Lurati A, et al.
Publicado: (2013) -
Challenges in the management of juvenile idiopathic arthritis with etanercept
por: Clare E Pain, et al.
Publicado: (2009) -
Update on the use of etanercept across a spectrum of rheumatoid disorders
por: Bernard Combe
Publicado: (2008)